The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRPT, OLLI and CC

NEW YORK, NY / ACCESSWIRE / October 25, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Class Period: September 6, 2017 to August 19, 2019
Lead Plaintiff Deadline: October 29, 2019

Throughout the class period, Sarepta Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) golodirsen, Sarepta's drug for the treatment of Duchenne muscular dystrophy, posed significant safety risks to patients; (ii) consequently, the New Drug Application package for golodirsen's accelerated approval was unlikely to receive Food and Drug Administration approval; and (iii) as a result, Sarepta's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SRPT: http://www.kleinstocklaw.com/pslra-1/sarepta-therapeutics-inc-loss-submission-form?id=4035&from=1

Ollies Bargain Outlet Holdings, Inc. (NASDAQ:OLLI)
Class Period: June 6, 2019 to August 28, 2019
Lead Plaintiff Deadline: November 18, 2019

The lawsuit alleges that throughout the class period, Ollies Bargain Outlet Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company suffered a supply chain issue that impacted the initial inventory available at new stores; (2) as a result, the Company lacked sufficient inventory to meet demand at certain store locations; (3) as a result, the Company's comparable store sales were likely to decrease quarter-over-quarter; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in OLLI: http://www.kleinstocklaw.com/pslra-1/ollies-bargain-outlet-holdings-inc-loss-submission-form?id=4035&from=1

The Chemours Company (NYSE:CC)
Class Period: February 16, 2017 to August 1, 2019
Lead Plaintiff Deadline: December 9, 2019

According to the complaint, The Chemours Company allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company's policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours' handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.

Learn about your recoverable losses in CC: http://www.kleinstocklaw.com/pslra-1/the-chemours-company-loss-submission-form?id=4035&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 564142